Abion Inc. Share Price

A203400

KR7203400007

Biotechnology & Medical Research

End-of-day quote Korea S.E. 14/08/2026			5-day change	1st Jan Change
676.00 ^KRW	-2.03%		0.00%	-78.40%

07/04	ABION Announces Preclinical Data Showing IFN-? Antibody Fusion Abn202 Outperforms Trop2-Targeting ADCs	CI
04/25/04	Abion To Divest 5.9 Billion Won Worth Of Shares In Vivozon Inc	RE

ABION Inc. is a Korea-based company principally engaged in the research, development and sales of pharmaceuticals. Along with its subsidiaries, the Company operates its business through four segments including product segment, contract research organization (CRO) service segment, research segment and other segment. The Product segment produces and sells diagnostic reagents, research reagents, and stem cell culture medium. The CRO Service segment provides histopathology analysis, molecular genetic analysis, cellular immunoassay, and antibody detection services. The Research segment is engaged in research and development of drugs for protein therapeutics, nucleic acid therapeutics, and antibody therapeutics.

Employees

Sector

Biotechnology & Medical Research

Calendar

08/10 Significant Split/Dividend

More about the company

Quotes

Date	Price	Change	Volume
14/26/14	₩676.00	-2.03%	21,69,199
13/26/13	₩690.00	-7.88%	32,52,426

End-of-day quote Korea S.E.

More quotes

Stock Market
Stocks
A203400 Stock

As early as today, start finding the best investment opportunities!

Market Cap	6.09TCr 4.39Cr 3.76Cr 3.52Cr 3.22Cr 6.05Cr 420.5Cr 6.13Cr 42Cr 16Cr 211.24Cr 17Cr 16Cr 698.68Cr	P/E 2024	-4.02x	P/E 2025	-7.21x
Enterprise Value	3.26TCr 2.35Cr 2.01Cr 1.88Cr 1.72Cr 3.24Cr 224.89Cr 3.28Cr 22Cr 8.68Cr 112.97Cr 8.83Cr 8.63Cr 373.66Cr	EV / Sales 2024	282x	EV / Sales 2025	288x
Free-Float	67.24%	Yield 2024 *	-	Yield 2025	-

07/04	ABION Announces Preclinical Data Showing IFN-? Antibody Fusion Abn202 Outperforms Trop2-Targeting ADCs	CI
04/25/04	Abion To Divest 5.9 Billion Won Worth Of Shares In Vivozon Inc	RE
30/24/30	Nuon Co., Ltd. completed the acquisition of 4.06% stake in ABION Inc. from KPM TECH Co., Ltd..	CI
26/24/26	KPM TECH Co., Ltd. announced that it has received KRW 5.999999711 billion in funding from ABION Inc.	CI
23/24/23	Nuon Co., Ltd. agreed to acquire 4.06% stake in ABION Inc. from KPM TECH Co., Ltd. for KRW 8 billion.	CI
23/24/23	ABION Inc. announced that it has received KRW 8.0011152 billion in funding from TELCON RF PHARMACEUTICAL. Inc.	CI
18/24/18	KPM TECH Co., Ltd. announced that it expects to receive KRW 5.999999711 billion in funding from ABION Inc.	CI
05/24/05	ABION Inc. completed the acquisition of 7.56% stake in Vivozon, Inc. from TELCON RF PHARMACEUTICAL. Inc..	CI
05/24/05	ABION Inc. announced that it has received KRW 20.019993378 billion in funding from TELCON RF PHARMACEUTICAL. Inc.	CI
11/24/11	ABION Inc. announced that it expects to receive KRW 20.019993378 billion in funding from TELCON RF PHARMACEUTICAL. Inc.	CI
11/24/11	ABION Inc. agreed to acquire 7.56% stake in Vivozon, Inc. from TELCON RF PHARMACEUTICAL. Inc. for KRW 20.1 billion.	CI
28/24/28	ABION Inc. announced that it expects to receive KRW 9.999995616 billion in funding from TELCON RF PHARMACEUTICAL. Inc.	CI
28/23/28	Abion Inc. announced that it has received KRW 7.999997049 billion in funding from TELCON RF PHARMACEUTICAL. Inc., Gencurix Inc.	CI

1 day	-2.03%
Current month	+1.96%
1 month	+3.05%
3 months	-64.57%
6 months	-81.06%
Current year	-78.40%

1 month	587	1,093
Current year	570	4,335
1 year	570	4,510
3 years	570	7,277.78
5 years	570	14,694.44
10 years	570	14,694.44

Manager	Title	Age	Since
Young-Gi Shin CEO	Chief Executive Officer	55	01/08/2010
Seong-Yun Woo DFI	Director of Finance/CFO	45	28/03/2025
Gi-Ryong Jang COO	Chief Operating Officer	46	01/01/2026

Abion Inc. Share Price

Stocks

A203400

KR7203400007

Biotechnology & Medical Research

Valuation: Abion Inc.

Chart: Abion Inc.

Latest news : Abion Inc.

Quotes and Performance

Course Extremes

Managers and Directors: Abion Inc.

Latest insider transactions

Bio Therapeutic Drugs

Financials

Company Profile

Quotes

Director	Title	Age	Since
Young-Gi Shin BRD	Director/Board Member	55	31/12/2014
Jin-Wook Yang BRD	Director/Board Member	56	25/03/2022
Geun-Chul Park BRD	Director/Board Member	70	-

Date	Insider	Type	Quantity	% Market Cap.
08/12/25	Sun-mi Chang	Free	27	0.0001%
08/12/25	Yang-mi Lim	Buy	115	0.0002%
08/12/25	Yang-mi Lim	Free	92	0.0002%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
ABION INC.	-2.03%	0.00%	-80.75%	-84.98%	4.39Cr
WUXI APPTEC CO., LTD.	-3.00%	+2.27%	+77.60%	+109.33%	7.21TCr
ARGENX SE	+1.90%	+23.53%	+56.60%	+97.76%	6.59TCr
BIONTECH SE	+5.12%	+25.22%	+5.24%	-0.82%	2.93TCr
INSMED INCORPORATED	+0.55%	+1.64%	-5.15%	+471.68%	2.75TCr
WUXI BIOLOGICS (CAYMAN) INC.	+2.74%	+12.98%	+62.84%	+28.14%	2.67TCr
GENMAB A/S	+0.47%	+6.12%	+36.66%	-13.79%	2.01TCr
PHARMAESSENTIA CORPORATION	+1.82%	-6.67%	+247.46%	+393.10%	1.82TCr
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	+0.94%	+3.36%	+18.55%	+532.94%	1.64TCr
EXELIXIS, INC.	+0.73%	+5.54%	+39.71%	+153.07%	1.34TCr
Average	+0.92%	+5.56%	+45.87%	+168.64%	2.9TCr
Weighted average by Cap.	+0.74%	+9.48%	+59.02%	+157.77%

	2024	2025
Net sales	76Cr 5L 5L 4L 4L 8L 5.24Cr 8L 51.91L 20.24L 2.63Cr 20.58L 20.13L 8.71Cr	88Cr 6L 5L 5L 5L 9L 6.08Cr 9L 60.14L 23.45L 3.05Cr 23.85L 23.33L 10Cr
Net income	-4.34TCr -3.13Cr -2.68Cr -2.51Cr -2.3Cr -4.31Cr -299.5Cr -4.37Cr -30Cr -12Cr -150.45Cr -12Cr -11Cr -497.63Cr	-2.91TCr -2.1Cr -1.8Cr -1.68Cr -1.54Cr -2.89Cr -200.65Cr -2.93Cr -20Cr -7.74Cr -100.8Cr -7.87Cr -7.7Cr -333.39Cr
Net Debt	1.4TCr 1.01Cr 86.82L 81.24L 74.36L 1.4Cr 97Cr 1.41Cr 9.6Cr 3.74Cr 49Cr 3.81Cr 3.72Cr 161.13Cr	-2.83TCr -2.04Cr -1.75Cr -1.64Cr -1.5Cr -2.82Cr -195.61Cr -2.85Cr -19Cr -7.55Cr -98Cr -7.68Cr -7.51Cr -325.02Cr